A qualitative estimate of the influence of halcinonide concentration and urea on the reservoir formation in the stratum corneum

Skin Pharmacology and Applied Skin Physiology

Volumn 12, Issue 1-2, 1999, Pages 85-89

  Clarys, Peter ^b   Gabard, B ^a   Barel, A O ^c  

^a Spirig AG   (Switzerland)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c NONE

Author keywords

Chromametry; Corticosteroid concentration; Skin blanching; Stratum corneum reservoir; Urea

Indexed keywords

CORTICOSTEROID; HALCINONIDE; UREA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG RETENTION; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SKIN COLOR; STRATUM CORNEUM; TOPICAL DRUG ADMINISTRATION; TOPICAL TREATMENT;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; COLORIMETRY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EPIDERMIS; FEMALE; GLUCOCORTICOIDS; HALCINONIDE; HUMANS; MALE; TIME FACTORS; UREA;

EID: 0033030306     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029849     Document Type: Article

References (14)

1. Vickers CFH: Existence of a reservoir in the stratum corneum. Arch Dermatol 1963;88:20-23.
2. Miselnicky SR, Lichtin L, Skar A, Bronaugh RL: The influence of solubility, protein binding, and percutaneous absorption on reservoir formation in skin. J Soc Cosmet Chem 1988;39:169-177.
3. Stoughton RB: Percutaneous absorption of drugs. Annu Rev Pharmacol Toxicol 1989;29:55-69.
4. Ritschel WA, Panchagnula R, Stemmer K, Ashraf M: Development of an intracutaneous depot for drugs. Binding, drug accumulation and retention studies, and mechanism of depot. Skin Pharmacol 1991;4:235-245.
5. Rougier A, Lotte C, Dupuis D: An original predictive method for in vivo percutaneous absorption studies. J Soc Cosmet Chem 1987;38: 397-417.
6. Piérard GE, Piérard-Franchimont C, Estrada JA: Comparative study of the activity and lingering effect of topical antifungals. Skin Pharmacol 1994;6:208-214.
7. Turpeinen M: Absorption of hydrocortisone from the skin reservoir in atopic dermatitis. Br J Dermatol 1991;124:358-360.
8. Hewitt PG, Hotchkiss SAM, Caldwell J: Cutaneous reservoir formation and localization after topical application of 4,4-methylene-bis-ortho(chloroaniline) and 4,4-methylenedianiline to rat and human skin in vitro; in Brain KR, James VJ, Walters KA (eds): Prediction of Percutaneous Penetration Methods, Measurements, Modelling. Cardiff, STS Publishing, 1993, vol 3b, pp 638-645.
9. Clarys P, Barel AO: The influence of a single topical corticosteroid application on the hydration state of the stratum corneum. J Dermatol Treat 1997;8:193-197.
10. Smith EW, Meyer E, Haigh JM: Accuracy and reproducibility of the multiple-reading skin blanching assay; in Maibach HI, Surber C (eds): Topical Corticosteroids. Basel, Karger, 1992, pp 65-73.
11. Clarys P, Wets L, Barel A, Gabard B: The skin blanching assay with halcinonide, influence of halcinonide concentration and application time. J Eur Acad Dermatol Venereol 1995;5:250-257.
12. Pershing LK, Lambert LD, Shah VP, Lam SY: Variability and correlation of chromameter and tape-stripping methods with the visual skin blanching assay in the quantitative assessment of topical 0.05% betamethasone dipropionate bioavailability in humans. Int J Pharm 1992;86:201-210.
13. Gabard B, Juch R, Treffel P,Bieli E, Clarys P, Barel A: Quantification of the skin blanching assay by colour measurements with the minolta chromameter: Influence of the vehicle and of the corticosteroid concentration; in Brain KR, James VJ, Walters KA (eds): Prediction of Percutaneous Penetration Methods, Measurements, Modelling. Cardiff, STS Publishing, 1993, vol 3b, pp 511-519.
14. Marks R: Adverse side effects from the use of topical corticosteroids; in Maibach HI, Surber C (eds): Topical Corticosteroids. Basel, Karger, 1992, pp 170-183.